Middle meningeal artery embolisation for chronic subdural haematomas
Closed for comments This consultation ended on at Request commenting lead permission
1 Draft recommendations
1.1 Middle meningeal artery embolisation for chronic subdural haematomas should be used only in research. Find out what only in research means on the NICE interventional procedures guidance page.
1.2 Further research should ideally be randomised controlled trials and report details of patient selection, technique used, rebleeding, functional outcomes, need for reintervention and length of hospital stay.
Why the committee made these recommendations
There were no randomised controlled trials (good quality clinical trials) and the evidence from observational studies was limited in quantity and quality. The evidence included a large number of people with chronic subdural haematomas, but only a small number had this procedure. The evidence included the procedure used at different treatment stages and with different aims. So, it is uncertain which group of patients will derive benefit from the procedure.
Overall, the evidence does not raise any safety concerns, although the procedure can have complications. However, there is uncertainty about the efficacy of the procedure. So, it should be used only in research.
How are you taking part in this consultation?
You will not be able to change how you comment later.
You must be signed in to answer questions